Browse the full record of transactions filed by Dreyer Scott, Vice-Président Exécutif et Directeur Commercial. Officer active across 2 companies, notably COLLEGIUM PHARMACEUTICAL, INC. In total, 8 filings have been recorded. Total volume traded: €386k. The latest transaction was disclosed on 18 February 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
Scott Dreyer is the EVP & Chief Commercial Officer at Collegium Pharmaceutical, Inc. He is responsible for the commercial strategy and business development of the company. His expertise is essential for Collegium's growth and innovation.